Recent advances in chemotherapy and targeted therapies for breast sarcoma
Although there is a growing understanding of genomic abnormalities associated with specific sarcoma subtypes, this knowledge has yet to be fully applied to personalized treatment strategies. Future research should focus on integrating genomic insights, enhancing trial design to improve patient's outcome. Robust interdisciplinary collaboration - combined with real-world data collection - is critical in improving treatment outcomes.
Authors
- Christophe Cisarovsky (ORCID: https://orcid.org/0000-0003-3341-2696)
- Ioannis A. Voutsadakis (ORCID: https://orcid.org/0000-0002-9301-5951)
- Ana Dolcan
- Laureline Wetterwald (ORCID: https://orcid.org/0000-0001-7935-743X)
- Daniela A. Ferraro (ORCID: https://orcid.org/0000-0001-5707-3161)
- Digklia Antonia
- Giovani Dei Tos
- Stephane Cherix
Institutions
- SHOWA Medical University Hospital (JP)
- University of Lausanne (CH)
Publication Details
- Journal
- Expert Review of Anticancer Therapy
- Published
- 2025-12-24
- DOI
- https://doi.org/10.1080/14737140.2025.2604619
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00